Rothschild Investment LLC Adaptive Biotechnologies Corp Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 10,305 shares of ADPT stock, worth $80,585. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,305
Previous 10,235
0.68%
Holding current value
$80,585
Previous $61.4 Million
24.78%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADPT
# of Institutions
227Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$235 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$114 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$91.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$83.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$73.7 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.12B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...